IP Library Granted Patent US 8,530,191
Granted Patent B2
US 8,530,191 · App. 12/714,900 · Granted Sep 10, 2013

Method for preventing formation of trisulfide derivatives of polypeptides

Inventors: Peter Becker (Virum, DK); Thorkild Christensen (Allerød, DK)
Assignee: Novo Nordisk A/S
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,530,191
App. No.
12/714,900
Granted
Sep 10, 2013
Kind
B2
Abstract

A method for reducing or substantially preventing formation of a trisulfide derivative of a polypeptide in a liquid medium containing the polypeptide ijn question comprises stripping the liquid medium with a gas, suitably a chemically unreactive gas such as nitrogen or argon.

Claims (3)

1. A method for reducing or substantially preventing formation of a trisulfide derivative of a polypeptide selected from recombinantly produced native human growth hormone (rhGH) and truncated forms thereof in a liquid medium containing said polypeptide, the method comprising stripping said liquid medium with a gas selected from the group consisting of nitrogen (N 2 ), helium (He), and argon (Ar), wherein said stripping is performed during post-production processing of said polypeptide, and wherein a sulfite or a mercapto compound is added to the liquid medium after production of said polypeptide.

2. A method according to claim 1 , wherein said polypeptide is subjected to one or more purification steps after the stripping procedure.

3. A method according to claim 2 , comprising at least one filtration step.

Priority Claims (1)
DK 2004 02022 · Dec 29, 2004 · national
Continuity (3)
Continuation 11813045
Provisional Application 60642628 · Jan 10, 2005
Related Publication 20100160236A1 · Jun 24, 2010